Shopping Cart
- Remove All
Your shopping cart is currently empty
Imatinib D4 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $197 | 7-10 days | |
| 5 mg | Preferential | 7-10 days |
| Description | Imatinib D4 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity. |
| Synonyms | STI571 D4, CGP-57148B D4 |
| Molecular Weight | 497.63 |
| Formula | C29H31N7O |
| Cas No. | 1134803-16-9 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.